FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 13:26:04 2024-05-13 EDT | ||
| 0.65 EUR | +4.84% |
|
| Current month | -37.50% | ||
| 1 month | -43.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 0.65 | +4.84% | 0 |
| 24-05-10 | 0.62 | 0.00% | 0 |
| 24-05-09 | 0.62 | -8.82% | 0 |
| 24-05-08 | 0.68 | -4.23% | 0 |
| 24-05-07 | 0.71 | 0.00% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 13, 2024 at 01:26 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UH12KT |
| ISIN | DE000UH12KT2 |
| Date issued | 2021-09-13 |
| Strike | 417.1 $ |
| Maturity | Unlimited |
| Parity | 153.37 : 1 |
| Emission price | 5.09 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.21 € |
|---|---|
| Lowest since issue | 0.54 € |
| Spread | 0.02 € |
| Spread % | 2.99% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
308.4
USD
Average target price
314.6
USD
Spread / Average Target
+2.01%
- Stock Market
- Certificates
- Certificat